Evidence map›Paper›PMID 33654197›Full record

ArticleOncogene2021

The role of miR-200b/c in balancing EMT and proliferation revealed by an activity reporter.

Paradesi Naidu Gollavilli, Beatrice Parma, Aarif Siddiqui, Hai Yang, Vignesh Ramesh, Francesca Napoli, Annemarie Schwab, Ramakrishnan Natesan, Dirk Mielenz, Irfan Ahmed Asangani and 3 more

Abstract read
In one paragraph

Article in Oncogene, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. A computational approach for perturbation-induced EMT transitions.NPJ systems biology and applications · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. A Narrative Review of Diabetic Macroangiopathy: From Molecular Mechanism to Therapeutic Approaches.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting.Journal of experimental & clinical cancer research : CR · 2021
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Paradesi Naidu GollavilliInterdisciplinary Center for Clinical Research (IZKF), Friedrich-Alexander University of Erlangen-Nuremberg (FAU), Erlangen, Germany.ORCID http://orcid.org/0000-0003-0956-1296
Beatrice ParmaInterdisciplinary Center for Clinical Research (IZKF), Friedrich-Alexander University of Erlangen-Nuremberg (FAU), Erlangen, Germany.
Aarif SiddiquiInterdisciplinary Center for Clinical Research (IZKF), Friedrich-Alexander University of Erlangen-Nuremberg (FAU), Erlangen, Germany.ORCID http://orcid.org/0000-0003-4308-3398
Hai YangDepartment of Surgery, Friedrich-Alexander University of Erlangen- Nuremberg (FAU) and University Hospital of Erlangen, Erlangen, Germany.
Vignesh RameshInterdisciplinary Center for Clinical Research (IZKF), Friedrich-Alexander University of Erlangen-Nuremberg (FAU), Erlangen, Germany.
Francesca NapoliInterdisciplinary Center for Clinical Research (IZKF), Friedrich-Alexander University of Erlangen-Nuremberg (FAU), Erlangen, Germany.
Annemarie SchwabInterdisciplinary Center for Clinical Research (IZKF), Friedrich-Alexander University of Erlangen-Nuremberg (FAU), Erlangen, Germany.
Ramakrishnan NatesanDepartment of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
Dirk MielenzDepartment of Molecular Immunology, Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany.ORCID http://orcid.org/0000-0002-1135-0642
Irfan Ahmed AsanganiDepartment of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
Thomas BrabletzDepartment of Experimental Medicine-I, Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany.ORCID http://orcid.org/0000-0003-2983-9048
Christian PilarskyDepartment of Surgery, Friedrich-Alexander University of Erlangen- Nuremberg (FAU) and University Hospital of Erlangen, Erlangen, Germany.
Paolo CeppiInterdisciplinary Center for Clinical Research (IZKF), Friedrich-Alexander University of Erlangen-Nuremberg (FAU), Erlangen, Germany. pceppi@bmb.sdu.dk.ORCID http://orcid.org/0000-0002-3632-8476

Funding

Role of MED1 in the AR-dependent transcription in advanced prostate cancerR01CA249210 · NCI · UNIVERSITY OF PENNSYLVANIA · PI ASANGANI, IRFAN AHMED · 2020 to 2024
$1.9M
NCI NIH HHS R01 CA249210
6 · The paper itself

Abstract

Since their discovery, microRNAs (miRNAs) have been widely studied in almost every aspect of biology and medicine, leading to the identification of important gene regulation circuits and cellular mechanisms. However, investigations are generally focused on the analysis of their downstream targets and biological functions in overexpression and knockdown approaches, while miRNAs endogenous levels and activity remain poorly understood. Here, we used the cellular plasticity-regulating process of epithelial-to-mesenchymal transition (EMT) as a model to show the efficacy of a fluorescent sensor to separate cells with distinct EMT signatures, based on miR-200b/c activity. The system was further combined with a CRISPR-Cas9 screening platform to unbiasedly identify miR-200b/c upstream regulating genes. The sensor allows to infer miRNAs fundamental biological properties, as profiling of sorted cells indicated miR-200b/c as a molecular switch between EMT differentiation and proliferation, and suggested a role for metabolic enzymes in miR-200/EMT regulation. Analysis of miRNAs endogenous levels and activity for in vitro and in vivo applications could lead to a better understanding of their biological role in physiology and disease.

Indexed as

Cell DifferentiationCell PlasticityCell ProliferationColorectal NeoplasmsEpithelial-Mesenchymal TransitionHCT116 CellsHumansMicroRNAsMicroRNAsMIRN200 microRNA, human

Identifiers

PMID33654197
PMCPMC7994202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.